Congress, FDA at Odds over Software as a Medical Device

The U.S. Food and Drug Administration (FDA) and members of Congress are at odds over whether software should be regulated as a medical device.

Both sides of the argument were made at a hearing held Nov. 19 by the House Energy and Commerce Subcommittee on Health which examined federal regulation of mobile medical apps and other health software. Continue reading